Participants in the ENACT-AMI trial undergo cardiac catheterization in which genetically altered stem cells, unaltered stem cells or a placebo is injected directly into the coronary artery near the damaged tissue. Heart Institute cardiologist Dr. Sandy Dick (right) performs the procedure on the trial's first participant.